Urinary miRNA-377 and miRNA-216a as biomarkers of nephropathy and subclinical atherosclerotic risk in pediatric patients with type 1 diabetes.

No abstract is available for this paper.

• Publication year

  2018

• Venue

  Journal of diabetes and its complications

• Publication date

  2018-02-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.jdiacomp.2017.10.014PMID 29175120
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Diabetic Kidney Disease

  2020cited by this paper
• Expression of CD4+CD28null T lymphocytes in children and adolescents with type 1 diabetes mellitus: Relation to microvascular complications, aortic elastic properties, and carotid intima media thickness

  2017cited by this paper
• Comparative microRNA profiling in relation to urinary albumin excretion in newly diagnosed hypertensive patients

  2016cited by this paper
• Circulating angiopoietin-2 levels in children and adolescents with type 1 diabetes mellitus: relation to carotid and aortic intima-media thickness

  2016cited by this paper
• Complication in diabetic nephropathy.

  2016cited by this paper
• Kallistatin as a marker of microvascular complications in children and adolescents with type 1 diabetes mellitus: Relation to carotid intima media thickness

  2015cited by this paper
• Intima media thickness measurement in children: A statement from the Association for European Paediatric Cardiology (AEPC) Working Group on Cardiovascular Prevention endorsed by the Association for European Paediatric Cardiology.

  2015cited by this paper
• Pterostilbene and allopurinol reduce fructose-induced podocyte oxidative stress and inflammation via microRNA-377.

  2015cited by this paper
• Diabetic kidney disease: a clinical update from Kidney Disease: Improving Global Outcomes.

  2015cited by this paper
• Diabetic nephropathy as a cause of end-stage renal disease in Tabuk area, Saudi Arabia: a four-year study.

  2014cited by this paper
• MicroRNA-377 Regulates Mesenchymal Stem Cell-Induced Angiogenesis in Ischemic Hearts by Targeting VEGF

  2014cited by this paper
• MiR-216a: a link between endothelial dysfunction and autophagy

  2014cited by this paper
• MicroRNAs: potential therapeutic targets in diabetic complications of the cardiovascular and renal systems

  2014cited by this paper
• Biomarkers in diabetic nephropathy: Present and future.

  2014cited by this paper
• Correction: Urinary MicroRNA Profiling in the Nephropathy of Type 1 Diabetes

  2013cited by this paper
• Urine miRNAs: potential biomarkers for monitoring progression of early stages of diabetic nephropathy.

  2013cited by this paper
• Carotid intimo-medial thickness [cIMT] and correlation to cardiac risk factors in adolescent type 1 diabetics

  2013cited by this paper
• Urinary MicroRNA Profiling in the Nephropathy of Type 1 Diabetes

  2013cited by this paper
• Diagnosis and Classification of Diabetes Mellitus

  2013cited by this paper
• Urinary miR-29 Correlates with Albuminuria and Carotid Intima-Media Thickness in Type 2 Diabetes Patients

  2013cited by this paper
• Oxidative stress in atherosclerosis: the role of microRNAs in arterial remodeling.

  2013cited by this paper
• Micro-RNA Expression in the Urinary Sediment of Patients with Chronic Kidney Diseases

  2012cited by this paper
• A translational study of urine miRNAs in acute myocardial infarction.

  2012cited by this paper
• Determinants of atherosclerosis in children and adolescents with diabetes type 1.

  2012cited by this paper
• MicroRNA and vascular remodelling in acute vascular injury and pulmonary vascular remodelling.

  2012cited by this paper
• Diabetes Complications: The MicroRNA Perspective

  2011cited by this paper
• MicroRNAs as mediators and therapeutic targets in chronic kidney disease

  2011cited by this paper
• Biological functions of microRNAs: a review

  2011cited by this paper
• A glimpse of various pathogenetic mechanisms of diabetic nephropathy.

  2011cited by this paper
• Carotid intima-media thickness and its relations with the complications in patients with type 1 diabetes mellitus.

  2010cited by this paper
• In patients with type 1 diabetes and new-onset microalbuminuria the development of advanced chronic kidney disease may not require progression to proteinuria.

  2010cited by this paper
• Regulation of Heme Oxygenase-1 Protein Expression by miR-377 in Combination with miR-217*

  2010cited by this paper
• Post-transcriptional Up-regulation of Tsc-22 by Ybx1, a Target of miR-216a, Mediates TGF-β-induced Collagen Expression in Kidney Cells*♦

  2010cited by this paper
• Review: The role of microRNAs in kidney disease

  2010cited by this paper
• Current issues in measurement and reporting of urinary albumin excretion.

  2009cited by this paper
• Growth curves for cardio-metabolic risk factors in children and adolescents.

  2009cited by this paper
• Real-Time Quantitative RT-PCR: Design, Calculations, and Statistics

  2009cited by this paper
• TGF-β activates Akt kinase via a microRNA-dependent amplifying circuit targeting PTEN

  2009cited by this paper
• Induction of heme oxygenase-1 protects against podocyte apoptosis under diabetic conditions.

  2009cited by this paper
• AAP Clinical Report on Lipid Screening in Children

  2009cited by this paper
• Diabetic Nephropathy: Mechanisms of Renal Disease Progression

  2008cited by this paper
• Expression of Somatostatin and Somatostatin Receptor Subtypes 1–5 in Human Normal and Diseased Kidney

  2008cited by this paper
• MicroRNA‐377 is up‐regulated and can lead to increased fibronectin production in diabetic nephropathy

  2008cited by this paper
• Risk Factors Related to Inflammation and Endothelial Dysfunction in the DCCT/EDIC Cohort and Their Relationship With Nephropathy and Macrovascular Complications

  2008cited by this paper
• Bedside neuropathy disability score compared to quantitative sensory testing for measurement of diabetic neuropathy in children, adolescents, and young adults with type 1 diabetes.

  2007cited by this paper
• Carotid intima-media thickness: an index for subclinical atherosclerosis in type 1 diabetes.

  2006cited by this paper
• Nephropathy in diabetes.

  2004cited by this paper
• Is Carotid Ultrasound a Useful Tool in Assessing Cardiovascular Disease in Individuals with Diabetes?

  2004cited by this paper
• Clinical practice guidelines for chronic kidney disease in adults: Part II. Glomerular filtration rate, proteinuria, and other markers.

  2004cited by this paper
• The importance of microalbuminuria as a cardiovascular risk indicator: A review.

  2002cited by this paper
• Does microalbuminuria predict diabetic nephropathy?

  2001cited by this paper
• The effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes.

  2001cited by this paper
• Molecular mechanism of diabetic nephropathy.

  2000cited by this paper
• Standards from birth to maturity for height, weight, height velocity, and weight velocity: British children, 1965. II.

  1966cited by this paper

• Cardiovascular risk factors and modern therapeutic strategies in children and adolescents with type 1 diabetes to prevent future diabetic angiopathy in the era of innovative miRNAs biomarkers

  2025cites this paper
• Bio fluid exosomes: promises, challenges, and future directions in translational medicine

  2025cites this paper
• Dapagliflozin Modulates MicroRNA Expression in Type 2 Diabetes Patients with Diabetic Nephropathy: A Retrospective Study

  2025cites this paper
• A systematic review and meta-analysis of microRNAs in the diagnosis of early diabetic kidney disease

  2025cites this paper
• Insights into diabetic nephropathy biomarkers with focus on existing indices and potential future developments

  2025cites this paper
• Recent advances in early diagnosis and treatment of T1D with miRNAs

  2025cites this paper
• Panel miRNAs are potential diagnostic markers for chronic kidney diseases: a systematic review and meta-analysis

  2024cites this paper
• Circulating non-coding RNA in type 1 diabetes mellitus as a source of potential biomarkers - An emerging role of sex difference.

  2024cites this paper
• The predictive value of miR-377 and phospholipase A2 in the early diagnosis of diabetic kidney disease and their relationship with inflammatory factors.

  2024cites this paper
• Role of Epigenetic Changes in the Pathophysiology of Diabetic Kidney Disease

  2024cites this paper
• Diagnostic Biomarkers of Microvascular Complications in Children and Adolescents with Type 1 Diabetes Mellitus—An Updated Review

  2024cites this paper
• Pediatric Diabetic Nephropathy: Novel Insights from microRNAs

  2023cites this paper
• Altered Expression of Vitamin D Metabolism Genes and Circulating MicroRNAs in PBMCs of Patients with Type 1 Diabetes: Their Association with Vitamin D Status and Ongoing Islet Autoimmunity

  2023cites this paper
• Fatty acid binding protein 1 (FABP1) and fatty acid binding protein 2 (FABP2) as a link between diabetic nephropathy and subclinical atherosclerosis in children and adolescents with type 1 diabetes.

  2023cites this paper
• Urinary microRNA in Diabetic Kidney Disease: A Literature Review

  2023cites this paper
• Biomarkers to Monitor Adherence to Gluten-Free Diet by Celiac Disease Patients: Gluten Immunogenic Peptides and Urinary miRNAs

  2022cites this paper
• The Role of Epigenetic Modifications in Late Complications in Type 1 Diabetes

  2022cites this paper
• Emerging Biomarkers for Early Detection of Chronic Kidney Disease

  2022cites this paper
• Genomic loci mispositioning in Tmem120a knockout mice yields latent lipodystrophy

  2022cites this paper
• Serum miR-377 Can Be Used as a Diagnostic Marker for Acute Coronary Syndrome and Can Regulate Proinflammatory Factors and Endothelial Injury Markers.

  2022cites this paper
• Identification of novel microRNAs associated with type 2 diabetes by an integrative bioinformatic analysis

  2022cites this paper
• Dysregulation of miR-638 in diabetic nephropathy and its role in inflammatory response

  2021cites this paper
• The Interplay Between Diet and the Epigenome in the Pathogenesis of Type-1 Diabetes

  2021cites this paper
• Demethylated miR-216a Regulates High Mobility Group Box 3 Promoting Growth of Esophageal Cancer Cells Through Wnt/β-Catenin Pathway

  2021cites this paper
• A 2 miRNAs-based signature for the diagnosis of atherosclerosis

  2021cites this paper
• miR-377 inhibition enhances the survival of trophoblast cells via upregulation of FNDC5 in gestational diabetes mellitus

  2021cites this paper
• Genomic loci mispositioning in Tmem120a knockout mice yields latent lipodystrophy

  2021cites this paper
• miR-375 Promotes Pancreatic Differentiation In Vitro by Affecting Different Target Genes at Different Stages

  2021cites this paper
• LncRNA MALAT1 promotes proliferation and migration of airway smooth muscle cells in asthma by downregulating microRNA-216a

  2021cites this paper
• miRNA-483–5p Targets HDCA4 to Regulate Renal Tubular Damage in Diabetic Nephropathy

  2021cites this paper
• Diabetes: discovery of insulin, genetic, epigenetic and viral infection mediated regulation

  2021cites this paper
• CircSMAD4 alleviates high glucose-induced inflammation, extracellular matrix deposition and apoptosis in mouse glomerulus mesangial cells by relieving miR-377-3p-mediated BMP7 inhibition

  2021cites this paper
• Identifying the differentially expressed microRNAs in autoimmunity: A systemic review and meta-analysis

  2020cites this paper
• Circulating miR-216a as a biomarker of metabolic alterations and obesity in women

  2020cites this paper
• Fecal microRNAs as Innovative Biomarkers of Intestinal Diseases and Effective Players in Host-Microbiome Interactions

  2020cites this paper
• MicroRNAs and Risk Factors for Diabetic Nephropathy in Egyptian Children and Adolescents with Type 1 Diabetes

  2020cites this paper
• MiR-377-3p inhibits atherosclerosis-associated vascular smooth muscle cell proliferation and migration via targeting neuropilin2

  2020cites this paper
• microRNA-216a protects against human retinal microvascular endothelial cell injury in diabetic retinopathy by suppressing the NOS2/JAK/STAT axis.

  2020cites this paper
• Urinary exosomes: Potential biomarkers for diabetic nephropathy

  2020cites this paper
• Role of sirtuin-1 in diabetic nephropathy

  2019cites this paper
• The early detection of atherosclerosis in type 1 diabetes: why, how and what to do about it

  2019cites this paper
• MicroRNAs: new biomarkers and promising therapeutic targets for diabetic kidney disease

  2019cites this paper
• Mini-review: clinical and molecular markers in early diabetic nephropathy

  2018cites this paper
• MicroRNA-377 Inhibits Atherosclerosis by Regulating Triglyceride Metabolism Through the DNA Methyltransferase 1 in Apolipoprotein E-Knockout Mice.

  2018cites this paper
• Modeling epigenetic modifications in renal development and disease with organoids and genome editing

  2018cites this paper